Really persuasive perspective from @joshua_schiffer & colleagues on the need for EARLY treatment of #COVID19, especially with antivirals. Very glad @ACTGNetwork protocol A5401/ACTIV-2 specifically is for this patient population. @IDSAInfo@OUPAcademic https://t.co/PaGYc61VkI
New in OFID: An analysis of internet search data suggests higher interest in infectious diseases training during the #COVID19 pandemic compared to other medical specialties. https://t.co/bViQ8witks
#OpenForumInfectDis#IDSAJournals#FutureofID#WeAreID
In this article Dr. Fauci clearly supports the randomized study of hydroxychloroquine plus azithromycin in a randomized trial (aka A5395) Anthony Fauci, MD, on COVID-19 Vaccines, Schools, and Larry Kramer https://t.co/XbQK0p7e3m
Dr. Fauci interview in JAMA 6/9/20. HAz COVID Trial Shout Out
“There are studies now that are looking at a combination of hydroxychloroquine and azithromycin compared to a placebo to see if there’s any effect there. That’s what we need,“
BREAKING: Trump administration finalizes rule that removes non-discrimination protections for LGBTQ people in health care & health insurance #NOH8 https://t.co/b8OGomtaii
My new national trial is open. It still still needs a blinded placebo controlled RCT to see if HCQ+Azithro workshttps://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19